Publication | Open Access

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON)

Hematological MalignancyDutch–belgian Cooperative TrialOncologyRandomised TrialHematologyMyeloid NeoplasiaPathologyMedicineRadiation OncologyCancer ResearchMolecular OncologyImatinib DiscontinuationHealth Sciences